Clinical Trials Insight: 700012092
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2008
At a glance
- Drugs APD 668 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Arena Pharmaceuticals
- 07 Jan 2008 Status changed from in progress to suspended.
- 14 Feb 2006 New trial record.